Previous studies demonstrated that the mTOR pathway was highly activated in HCC tissues, cirrhotic liver tissues from HCC patients, high-grade HCC, and poorer prognostic subtype [23–25]. The gene discussed is MTOR; the disease is hepatocellular carcinoma.